Helius Health Technology Company has begun accumulating a Solana fund, purchasing over 760,000 SOL with plans to expand its stake using 335 million dollars in cash reserves. This move demonstrates confidence in the Solana ecosystem and its yield-generating design.
Solana Fund Launches for Helius with Initial Purchase of 175 Million Dollars
Helius Health Technology Company (NASDAQ: HSDT) has made its first major move into digital assets, announcing the purchase of 760,190 SOL tokens. The purchase was made at an average price of 231 dollars per token as part of the company's newly launched Solana-focused treasury strategy.
In addition to its current stake, Helius stated that it has over $335 million in cash reserves to purchase more SOL. By prioritizing Solana, the company aims to become a long-term holder of the native tokens of this network.
Helius emphasizes that their strategy supports the development and security of tokenized networks, positioning the company as a player in the treasury of digital assets and a healthcare technology company.
“We are very pleased to receive support from many partners in the Solana ecosystem, including staking providers, DeFi protocols, and others. We value the responsibility of maximizing shareholder value and are eager to execute our plan,” said Joseph Chee, Executive Chairman of Helius Medical.
This move places HSDT on the growing list of companies integrating blockchain exposure into their balance sheets, while reinforcing confidence in Solana's role as a leading smart contract network.
